Oslo, Norway, 20 August 2013
Please find attached the presentation and report for Q2 2013 and 1H 2013 for PCI Biotech Holding ASA. The second quarter presentation will be held the 20 August at 0800 at Felix Konferansesenter.
Kind regards,
Per Walday
CEO
Email: pw@pcibiotech.no
Mobil: +47 917 93 429
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
